“…Considering the independent importance of five-membered heterocycles and aryl fluorides in the pharmaceutical industry, there is a surprising lack of five-membered heteroaryl fluorides that have been prepared and studied for potential biological activity. 7 This is likely due to the limited methods available for the fluorination of five-membered heteroarenes, 8 which include thermal 9a or photochemical 9b Balz–Schiemann reactions, Halex reactions, 10 electrophilic fluorinations of metalated heteroarenes, 11 and direct fluorinations with F 2 . 12 All of these methods suffer from severe drawbacks in terms of safety, functional group tolerance, generality, and/or formation of complex mixtures of products, which limit their utility.…”